Abstract
Aminoglycosides are known to cause oxidative stress related toxicities and tissue injuries. Present study was planned to evaluate the effect of aminoglycosides on blood oxidative stress parameters in mice and free radical scavenging potential of cephalosporins, when combined as a single injection with aminoglycosides using chemical vector mediated technology. Mus musculus mice were divided into five groups: Control group animals (treated with normal saline), amikacin treated group, tobramycin treated group, cefepime + amikacin treated group and ceftazidime + tobramycin treated group. A significant improvement in superoxide dismutase (SOD), catalase activities, along with malonaldialdehyde (MDA) levels and creatinine levels were observed in fixed dose combination of cephalosporins and aminoglycosides treated groups as compared to aminoglycosides alone (amikacin and tobramycin) treated groups. These findings indicate that on combining cephalosporins with aminoglycosides using chemical vector mediated technology prevents oxidative stress related tissues injury induced by aminoglycosides.
Keywords: Cephalosporin, aminoglycoside, free radicals, catalase, superoxide dismutase, malonaldialdehyde
Current Drug Therapy
Title: Anti Oxidant Property of New Cephalosporin-Aminoglycoside Fixed Dose Combination
Volume: 4 Issue: 1
Author(s): Manu Chaudhary, Arvind Soni, Vivek Kumar Dwivedi and Rajesh Sehgal
Affiliation:
Keywords: Cephalosporin, aminoglycoside, free radicals, catalase, superoxide dismutase, malonaldialdehyde
Abstract: Aminoglycosides are known to cause oxidative stress related toxicities and tissue injuries. Present study was planned to evaluate the effect of aminoglycosides on blood oxidative stress parameters in mice and free radical scavenging potential of cephalosporins, when combined as a single injection with aminoglycosides using chemical vector mediated technology. Mus musculus mice were divided into five groups: Control group animals (treated with normal saline), amikacin treated group, tobramycin treated group, cefepime + amikacin treated group and ceftazidime + tobramycin treated group. A significant improvement in superoxide dismutase (SOD), catalase activities, along with malonaldialdehyde (MDA) levels and creatinine levels were observed in fixed dose combination of cephalosporins and aminoglycosides treated groups as compared to aminoglycosides alone (amikacin and tobramycin) treated groups. These findings indicate that on combining cephalosporins with aminoglycosides using chemical vector mediated technology prevents oxidative stress related tissues injury induced by aminoglycosides.
Export Options
About this article
Cite this article as:
Chaudhary Manu, Soni Arvind, Dwivedi Kumar Vivek and Sehgal Rajesh, Anti Oxidant Property of New Cephalosporin-Aminoglycoside Fixed Dose Combination, Current Drug Therapy 2009; 4 (1) . https://dx.doi.org/10.2174/157488509787081877
DOI https://dx.doi.org/10.2174/157488509787081877 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Bioorganic Compounds Produced by the Fungus Monascus and their Use in Health Sciences and Medicine
Mini-Reviews in Organic Chemistry Solution-Phase Parallel Synthesis of N-Arylisoquinuclidines
Letters in Drug Design & Discovery Influence of Lifestyle Measures on Hypertriglyceridaemia
Current Drug Targets Comparative Studies on Phospholipase A2 as a Marker for Gut Microbiota- liver-brain Axis in a rodent Model of Autism
Current Proteomics Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence
CNS & Neurological Disorders - Drug Targets Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
Current Pharmaceutical Design Impacts and Concerns for vCJD in Blood Transfusion: Current Status
Current Molecular Medicine Natural Product as Substrates of ABC Transporters: A Review
Recent Patents on Anti-Cancer Drug Discovery Mass Spectrometry in Drug Discovery: A Current Review
Current Drug Discovery Technologies Pregabalin Dependence: A Case Report
Current Drug Safety Regulatory Cascade of Neuronal Loss and Glucose Metabolism
CNS & Neurological Disorders - Drug Targets Melatonin and Regulation of Immune Function: Impact on Numerous Diseases
Current Aging Science Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Inflammation & Allergy - Drug Targets (Discontinued) Towards Practical Cognitive Assessment for Detection of Early Dementia: A 30-Minute Computerized Battery Discriminates as Well as Longer Testing
Current Alzheimer Research The Associations between Central Nervous System Diseases and Haemostatic Disorders
CNS & Neurological Disorders - Drug Targets Mitochondrial Therapeutics for Cardioprotection
Current Pharmaceutical Design Neuroprotective Effects of Lithium in Human Brain? Food for Thought
Current Alzheimer Research Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design